|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Amortization of debt discount and imputed interest expense | |||||
| Financing costs | |||||
| Loss on derivative liability | |||||
| Staking rewards | |||||
| Change in fair value of derivative liability | |||||
| Net change in fair value of digital assets and digital assets receivable | |||||
| Net change in fair value of digital assets fund investment | |||||
| Realized gain/loss on sale of digital assets | |||||
| Stock-based compensation expense | |||||
| Foreign exchange loss (gain) | |||||
| Depreciation expense | |||||
| Amortization expense | |||||
| Goodwill and fixed asset impairment | |||||
| Fixed asset impairment | |||||
| Provision for (reversal of) inventory reserve | |||||
| Non-cash operating lease expense | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Other receivables | |||||
| Inventory | |||||
| Prepaid expense and other current assets | |||||
| Operating lease liabilities | |||||
| Accounts payable | |||||
| Accrued and other current liabilities | |||||
| Deferred revenue | |||||
| Other liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Digital assets purchased | |||||
| Digital assets sold | |||||
| Digital assets receivable purchased | |||||
| Digital assets fund investment | |||||
| Purchase of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of common stock in ATM | |||||
| Proceeds from issuance of warrants | |||||
| Proceeds from issuance of warrants and common stock warrants in private placement | |||||
| Proceeds from exercise of warrants | |||||
| Share issuance costs | |||||
| Proceeds from issuance of notes payable | |||||
| Repayment of notes payable | |||||
| Net cash provided by financing activities | |||||
| Effect of currency exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental cash flow information | |||||
| Non-cash investing and financing transactions: | |||||
| Digital assets received in-kind from private placement | |||||
| Purchase of digital assets with stablecoins | |||||
| Derivative warrant liability reclassified to equity on exercise of warrants | |||||
| Derivative warrant liability reclassified to equity on warrant amendment | |||||
| Deferred offering costs reclassified to equity upon public offering | |||||
Loading...